We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $287M
1-Year Est. Return 23.01%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+23.01%
3 Year Est. Return
+71.9%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$5.42M
Cap. Flow
+$136K
Cap. Flow %
0.08%
Top 10 Hldgs %
41.51%
Holding
146
New
4
Increased
87
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
NOBL icon
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
+$347K
2
VPU
Vanguard Utilities ETF
VPU
+$302K
3
BMY icon
Bristol-Myers Squibb
BMY
+$260K
4
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$255K
5
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$250K

Top Sells

Rank Stock Value
1
PGX icon
Invesco Preferred ETF
PGX
+$1.85M
2
GSK icon
GSK
GSK
+$864K
3
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$325K
4
UPS icon
United Parcel Service
UPS
+$212K
5
DOW icon
Dow Inc
DOW
+$203K

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.19%
2 Financials 17.43%
3 Technology 17.31%
4 Communication Services 4.14%
5 Healthcare 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLD icon
126
Prologis
PLD
$128B
$262K 0.15%
2,329
-515
-18% -$57K
BSCP
127
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$260K 0.15%
12,720
-1,113
-8% -$22.8K
DIA icon
128
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$44.9B
$257K 0.14%
657
+1
+0.2% +$388
ARCC icon
129
Ares Capital
ARCC
$13.9B
$253K 0.14%
12,134
+56
+0.5% +$1.17K
VTWO icon
130
Vanguard Russell 2000 ETF
VTWO
$16.8B
$252K 0.14%
3,076
+5
+0.2% +$409
DVN icon
131
Devon Energy
DVN
$53.5B
$246K 0.14%
5,185
+1
+0% +$50
VOO icon
132
Vanguard S&P 500 ETF
VOO
$1.04T
$243K 0.14%
+486
New +$234K
BMY icon
133
Bristol-Myers Squibb
BMY
$129B
$241K 0.14%
+5,801
New +$260K
ABT icon
134
Abbott
ABT
$178B
$239K 0.13%
2,304
– –
SMH icon
135
VanEck Semiconductor ETF
SMH
$70.9B
$234K 0.13%
+897
New +$210K
VUG icon
136
Vanguard Morningstar Growth ETF
VUG
$228B
$221K 0.12%
3,552
+48
+1% +$2.8K
IJH icon
137
iShares Core S&P Mid-Cap ETF
IJH
$121B
$218K 0.12%
3,730
– –
PFXF icon
138
VanEck Preferred Securities ex Financials ETF
PFXF
$2.38B
$217K 0.12%
12,525
-264
-2% -$4.58K
XOM icon
139
ExxonMobil
XOM
$672B
$214K 0.12%
+1,861
New +$217K
TLT icon
140
iShares 20+ Year Treasury Bond ETF
TLT
$46.8B
$211K 0.12%
2,299
+5
+0.2% +$456
AGNC icon
141
AGNC Investment
AGNC
$11.7B
$166K 0.09%
17,349
-3,921
-18% -$37.5K
CHPT icon
142
ChargePoint
CHPT
$277M
$27K 0.02%
882
-820
-48% -$26.7K
DOW icon
143
Dow Inc
DOW
$20.8B
– –
-3,504
Closed -$203K
GSK icon
144
GSK
GSK
$101B
– –
-20,146
Closed -$864K
MA icon
145
Mastercard
MA
$495B
– –
-420
Closed -$202K
UPS icon
146
United Parcel Service
UPS
$84.3B
– –
-1,423
Closed -$212K
2 3 4 5
6

Similar funds

AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return
SRWM
Shira Ridge Wealth Management Larkspur, California $287M AUM 23.34% 1-Year Est. Return
TWM
Trueblood Wealth Management Lima, Ohio $286M AUM 27.34% 1-Year Est. Return
MC
Metavasi Capital Larchmont, New York $287M AUM 97.9% 1-Year Est. Return
BFA
Brown Financial Advisors Milford, Ohio $286M AUM 19.63% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $287M AUM 38.81% 1-Year Est. Return
PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
SMTF
Sphera Management Technology Funds Tel Aviv, Israel $286M AUM 63.73% 1-Year Est. Return

O'Rourke & Company's Q2 2024 Portfolio in Review

As of Q2 2024, O'Rourke & Company held 146 positions worth $178M, up 3.1% from $172M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

O'Rourke & Company's Q2 2024 filing shows 4 new, 87 increased, 32 reduced and 4 closed positions. Its largest new stake was Bristol-Myers Squibb: 5,801 shares worth $241K. The largest sale was Invesco Preferred ETF, an estimated $1.85M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Financials and Technology.

  • O'Rourke & Company's largest Q2 2024 buy was Bristol-Myers Squibb: 5,801 shares worth $241K.
  • O'Rourke & Company added most to ProShares S&P 500 Dividend Aristocrats ETF in Q2 2024, an estimated $347K increase.
  • O'Rourke & Company's biggest Q2 2024 reduction was Invesco Preferred ETF, cutting an estimated $1.85M.
  • O'Rourke & Company fully exited GSK in Q2 2024, selling an estimated $864K.
  • O'Rourke & Company's ten largest holdings make up 42% of its $178M portfolio in Q2 2024.
  • O'Rourke & Company opened 4 new positions and closed 4 in Q2 2024.
  • O'Rourke & Company's portfolio value rose 3.1% quarter-over-quarter to $178M.

Based on O'Rourke & Company's 13F filing for Q2 2024, filed 18 Jul 2024.